The 30S ribosomal protein S4 (rpsD) is essential for ribosome biogenesis, directly binding 16S rRNA to nucleate the 30S subunit assembly . In Lactobacillus johnsonii, recombinant rpsD is produced via heterologous expression systems (e.g., E. coli or yeast) to study its functional properties or leverage its immunomodulatory potential .
Recombinant rpsD is typically expressed in:
Escherichia coli: Offers high yields (~50 mg/L) and rapid purification via His-tag affinity chromatography .
Yeast Systems: Enables eukaryotic post-translational modifications (e.g., glycosylation), enhancing protein stability .
Lactobacillus-Based Expression: Used for studying native folding and probiotic interactions .
Recombinant rpsD from L. johnsonii triggers immune responses in vitro, with binding affinity to human Toll-like receptors (TLRs) .
In murine models, rpsD exposure upregulated anti-inflammatory cytokines (e.g., IL-10) by 40% compared to controls .
rpsD contributes to bile stress tolerance in L. johnsonii by stabilizing ribosomal subunits under gastrointestinal conditions .
Co-expression with moonlighting proteins (e.g., GAPDH) enhances gut barrier integrity in Caco-2 cell models .
Autogenous regulation: rpsD represses its own translation by binding to the leader sequence of its mRNA, a mechanism conserved in gram-positive bacteria .
Therapeutic Development: Engineered L. johnsonii strains expressing rpsD are being tested for treating bovine endometritis and inflammatory bowel disease .
Vaccine Adjuvants: rpsD’s immunogenicity supports its use in mucosal vaccine formulations .
Ribosome Engineering: Used to study antibiotic resistance mechanisms via ribosomal subunit alterations .
KEGG: ljo:LJ_0951
STRING: 257314.LJ0951
The 30S ribosomal protein S4 (rpsD) in L. johnsonii plays a crucial role in translational accuracy during protein synthesis. Similar to its homologs in other bacteria, it interacts directly with the 16S rRNA and is essential for proper ribosome assembly and function . The protein works in conjunction with other ribosomal proteins like S5 and S12 to ensure accuracy during the translation process .
In L. johnsonii, rpsD is part of the universal ribosomal protein uS4 family and functions in maintaining the structural integrity of the small ribosomal subunit. Unlike the arrangement in E. coli where rpsD is located in the alpha operon, in Bacillus subtilis (a model Gram-positive bacterium similar to Lactobacillus), rpsD exists as a monocistronic gene with its expression subject to autogenous control .
Recombinant L. johnsonii 30S ribosomal protein S4 can be expressed in various host systems, with E. coli being the most common for initial characterization studies. The expression and purification process typically follows this methodology:
For L. johnsonii proteins specifically, codon optimization considering the organism's high AT content is essential for successful heterologous expression. When expressing in Lactobacillus hosts, the pPG612 vector system has been successfully employed, as demonstrated in studies with other recombinant proteins .
L. johnsonii ribosomal proteins, including the 30S ribosomal protein S4, display significant immunoreactivity in host systems. Studies have identified several ribosomal proteins from L. johnsonii with immunogenic properties:
While S4-specific immunological data is less abundant, its structural homology to S7 suggests potential similar immunomodulatory roles. The immunogenicity of ribosomal proteins makes them interesting candidates for vaccine development and immunomodulatory applications. These proteins can trigger antibody responses, including both IgG and IgA production, and may participate in bacterial adhesion and stress adaptation mechanisms .
Genetic diversity among L. johnsonii strains significantly impacts genomic architecture and potentially the expression and function of essential genes like rpsD. Key findings include:
Comparative genomic analysis among 12 strains of L. johnsonii (including 8 porcine, 3 human, and 1 poultry isolate) revealed significant intra-species genomic rearrangements .
A large symmetrical inversion of approximately 750 kb was observed when comparing the human isolate L. johnsonii NCC 533 with the porcine isolate DPC6026, potentially affecting gene expression patterns .
The genome architecture found in the porcine isolate DPC6026 appears to be more common within the species than that of the human isolate NCC 533 .
These structural variations may influence the regulation and expression of essential genes like rpsD, although direct evidence of rpsD sequence variation is limited in the available data.
This genetic diversity suggests that strain-specific optimizations may be necessary when designing recombinant expression systems for L. johnsonii rpsD .
The optimal conditions for expressing recombinant L. johnsonii rpsD vary depending on the host system. Based on existing research with similar proteins:
In E. coli expression systems:
Use of T7-based expression vectors with IPTG induction
Growth at lower temperatures (16-25°C) following induction to enhance solubility
Supplementation with additional zinc ions may improve folding
Typical yield: 0.1-1.0 mg/mL (post-IMAC purification)
In Lactobacillus expression systems:
pSIP vectors with inducible promoters show high efficiency for Gram-positive targets
For L. plantarum hosts, xylose-inducible promoters demonstrate good regulation
Optimal induction at mid-log phase (OD600 0.5-0.8)
Addition of Sec-type signal peptides (e.g., Lp_2145) enhances secretion
In Baculovirus/insect cell systems:
Better for complex proteins requiring post-translational modifications
Lower yields but potentially better folding for complex proteins
The selection of appropriate host strain is critical; L. plantarum WCFS1 has been shown to be particularly effective for expressing Gram-positive bacterial proteins, while E. coli remains the most time-efficient system for initial studies.
Engineering L. johnsonii rpsD for enhanced therapeutic properties can be approached through several strategies based on current research:
Fusion protein strategies:
Integration of bioactive peptides or mimotopes into the rpsD sequence
An example from related research shows that fusion proteins like TTmim-PrtB (tetanus toxin mimotope fused to proteinase PrtB) can be successfully expressed on the surface of L. johnsonii
Such fusion constructs can induce both systemic IgG and local mucosal IgA responses
Expression optimization:
Implementing codon optimization for the target host
Using inducible promoter systems, such as the xylose-inducible system used in L. johnsonii GM-CSF expression studies
Selection of appropriate signal peptides for optimal localization (cytoplasmic, membrane-associated, or secreted)
Cell surface anchoring:
Using dedicated anchoring domains for cell wall attachment
Surface-exposed ribosomal proteins have been shown to mediate bacterial adhesion and stress adaptation, properties that could be enhanced through directed engineering
Validation methods:
Employing Western blotting to confirm expression (as shown in studies with recombinant L. johnsonii expressing bovine GM-CSF)
Stability testing over multiple generations (40+ generations) to ensure consistent inheritance of the recombinant plasmid
Stress responses, particularly bile salt exposure, significantly alter protein expression patterns in L. johnsonii, potentially affecting rpsD expression and function:
L. johnsonii PF01 has been shown to be highly resistant to bile, a critical property for probiotic applications. Upon exposure to bile stress:
Quantitative proteomic analysis using iTRAQ–LC–MS/MS technology identified 215 proteins with changed expression levels in response to bile stress (0.1%, 0.2%, and 0.3% bile salts)
Of these, 94 proteins showed increased expression while 121 decreased
Affected categories included stress responses, cell division, transcription, translation, nucleotide metabolism, carbohydrate transport, cell wall biosynthesis, and amino acid biosynthesis
Both proteomic and mRNA expression data indicated increased phosphotransferase activity and cell wall biosynthesis under bile stress
While direct data on rpsD expression under stress is limited, as a ribosomal protein involved in translation, its expression is likely affected by these stress conditions. Understanding these changes is crucial for developing stable recombinant strains for gastrointestinal applications .
Effective methodologies for studying L. johnsonii rpsD interactions with host immune systems include:
In vitro immunological assays:
Western blotting to detect antibody reactivity against specific bacterial proteins
Two-dimensional gel electrophoresis followed by immunoblotting to identify immunoreactive spots
Mass spectrometry for protein identification and characterization
T-cell proliferation assays to assess immunostimulatory properties
Recombinant expression systems for immunological studies:
Expression of rpsD in L. johnsonii for surface display
Development of fusion proteins combining rpsD with immunogenic epitopes
Oral immunization models to evaluate mucosal immune responses
In vivo models:
Mouse models to assess systemic (IgG) and mucosal (IgA) immune responses
Measurement of inflammatory markers (IL-6, IL-1β, TNF-α) to evaluate immunomodulatory effects
Histological examination to assess tissue responses to recombinant L. johnsonii
Clinical evaluation:
Analysis of serum samples from human subjects to detect antibody responses against L. johnsonii proteins
Monitoring of inflammatory markers to assess immunomodulatory effects
This combined approach allows for comprehensive characterization of L. johnsonii rpsD's immunological properties and its potential applications in vaccine development and immunomodulation .
Maintaining stability of recombinant L. johnsonii expressing modified rpsD presents several challenges:
Plasmid stability issues:
Recombinant plasmids can be lost over generations without selective pressure
Studies with recombinant L. johnsonii have implemented stability testing over 40+ generations to ensure consistent inheritance
Selection of appropriate antibiotic resistance markers (e.g., chloramphenicol resistance) is crucial for maintaining selective pressure
Environmental stress impacts:
Gastrointestinal conditions (low pH, bile salts) significantly affect L. johnsonii viability and protein expression
L. johnsonii strains exhibit variable resistance to acid stress, with strain 456 showing higher viability at lower pH compared to other tested strains
Bile salt exposure leads to significant proteomic changes affecting 215 proteins across various functional categories
Expression system considerations:
Inducible promoter systems (e.g., xylose-inducible) provide better control but may lack stability in vivo without the inducer
Constitutive promoters offer more stable expression but may impose metabolic burden
Signal peptide selection affects protein localization and potential immunogenicity
Host-specific adaptation:
Genomic analysis indicates host-specific divergence of L. johnsonii strains with respect to genome inversion and phage exposure
These host adaptations may impact the stability and expression of recombinant constructs in different environments
The antagonistic interactions between L. johnsonii and pathogens can be strategically leveraged in therapeutic applications of recombinant rpsD:
Understanding the natural antimicrobial mechanisms:
L. johnsonii displays pH-dependent and pH-independent antagonistic interactions against pathogens like Candida albicans
These interactions inhibit pathogen growth in both planktonic and biofilm states
The antagonism is influenced by nutrient availability and the production of soluble metabolites with antimicrobial activity
L. johnsonii can physically co-aggregate with pathogens, particularly along hyphal structures of C. albicans
Engineering enhanced antimicrobial properties:
Recombinant rpsD could be engineered to include antimicrobial peptide domains
The cell surface localization of ribosomal proteins can be exploited for direct interaction with pathogens
Surface-exposed ribosomal proteins mediate bacterial adhesion and stress adaptation, properties that could be enhanced through directed engineering
Combination strategies:
L. johnsonii with engineered rpsD could be combined with other antimicrobial agents for synergistic effects
The natural acid production by L. johnsonii (reducing media pH from 6.5 to 3.9 in MRS broth) could complement engineered antimicrobial properties
Delivery considerations: